Sensient Technologies Corp SXT
We take great care to ensure that the data presented and summarized in this overview for SENSIENT TECHNOLOGIES CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SXT
View all-
Black Rock Inc. New York, NY6.43MShares$604 Million0.01% of portfolio
-
Freemont Capital Pte LTD Singapore, U06.3MShares$592 Million27.36% of portfolio
-
Winder Investment Pte LTD6.3MShares$592 Million18.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.96MShares$466 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.29MShares$215 Million0.1% of portfolio
-
State Street Corp Boston, MA1.61MShares$151 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.04MShares$97.6 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$94.5 Million0.01% of portfolio
-
Westwood Holdings Group Inc Dallas, TX1MShares$94.2 Million0.72% of portfolio
-
Congress Asset Management CO717KShares$67.3 Million0.47% of portfolio
Latest Institutional Activity in SXT
Top Purchases
Top Sells
About SXT
Sensient Technologies Corporation, together with its subsidiaries, develops, manufactures, and markets colors, flavors, and other specialty ingredients in North America, Europe, the Asia Pacific, and internationally. It operates through three segments: Flavors & Extracts Group, Color Group, and Asia Pacific Group. The company offers flavor-delivery systems, and compounded and blended products; ingredient products, such as essential oils, natural and synthetic flavors, and natural extracts; and chili powder, paprika, and chili pepper, as well as dehydrated vegetables comprising parsley, celery, and spinach to the food, beverage, personal care, and household-products industries. It also provides natural and synthetic color systems for use in foods, beverages, pharmaceuticals, and nutraceuticals; colors and other ingredients for cosmetics, such as active ingredients, solubilizers, and surface treated pigments; pharmaceutical and nutraceutical excipients, including colors, flavors, coatings, and nutraceutical ingredients; and technical colors for industrial applications under the Sensient Food Colors, Sensient Pharmaceutical Coating Systems, Sensient Cosmetic Technologies, and Sensient Industrial Colors trade names. The company was incorporated in 1882 and is headquartered in Milwaukee, Wisconsin.
Insider Transactions at SXT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Essie Whitelaw Director |
SELL
Open market or private sale
|
Direct |
3,985
-18.88%
|
$378,575
$95.02 P/Share
|
|
Nov 20
2025
|
Essie Whitelaw Director |
SELL
Open market or private sale
|
Direct |
533
-2.46%
|
$49,569
$93.22 P/Share
|
|
Nov 04
2025
|
David J. Plautz VP and Treasurer |
BUY
Open market or private purchase
|
Direct |
2,150
+41.76%
|
$197,800
$92.98 P/Share
|
|
Nov 03
2025
|
Joseph Carleone Director |
BUY
Open market or private purchase
|
Direct |
1,000
+4.27%
|
$91,000
$91.26 P/Share
|
|
Aug 11
2025
|
Paul Manning Chairman, President & CEO |
BUY
Open market or private purchase
|
Indirect |
20
+20.0%
|
$2,320
$116.94 P/Share
|
|
Aug 06
2025
|
Sharad P Jain Director |
SELL
Open market or private sale
|
Direct |
1
-0.02%
|
$114
$114.14 P/Share
|
|
May 09
2025
|
Mario Ferruzzi Director |
SELL
Open market or private sale
|
Direct |
1,668
-17.35%
|
$158,460
$95.45 P/Share
|
|
Apr 24
2025
|
Joseph Carleone Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+6.11%
|
-
|
|
Apr 24
2025
|
Brett W Bruggeman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
168
-5.89%
|
$13,440
$80.14 P/Share
|
|
Apr 24
2025
|
Brett W Bruggeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+32.7%
|
-
|
|
Apr 24
2025
|
Carol R Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-9.36%
|
$49,520
$80.14 P/Share
|
|
Apr 24
2025
|
Carol R Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+17.32%
|
-
|
|
Apr 24
2025
|
Mario Ferruzzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-6.05%
|
$49,520
$80.14 P/Share
|
|
Apr 24
2025
|
Mario Ferruzzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+11.93%
|
-
|
|
Apr 24
2025
|
Gebhardt Deborah Mc Keithan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
546
-3.26%
|
$43,680
$80.14 P/Share
|
|
Apr 24
2025
|
Gebhardt Deborah Mc Keithan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+7.64%
|
-
|
|
Apr 24
2025
|
Donald W Landry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-5.92%
|
$49,520
$80.14 P/Share
|
|
Apr 24
2025
|
Donald W Landry Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+11.7%
|
-
|
|
Apr 24
2025
|
Sharad P Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,386
+19.33%
|
-
|
|
Apr 24
2025
|
Essie Whitelaw Director |
SELL
Payment of exercise price or tax liability
|
Direct |
619
-2.78%
|
$49,520
$80.14 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 12.5K shares |
|---|---|
| Open market or private purchase | 3.17K shares |
| Exercise of conversion of derivative security | 40K shares |
| Payment of exercise price or tax liability | 36.4K shares |
|---|---|
| Open market or private sale | 6.19K shares |